Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 307Breast 196Sarcoma 112Other hematologic neoplasm 101Gynecologic 43CNS 38Genitourinary 37Gastrointestinal 34Plasma cell 26Thoracic 13Other solid neoplasm 13Endocrine 10Head & Neck 8Tumor-Agnostic 7Dermatologic 5Myeloid 4Classical hematology 3NET 2Other 1

Conditions

Obesity 1Breast Neoplasms 1Body Weight 1

Interventions

Exercise 15Metformin 14Surveys and Questionnaires 12Radiotherapy 9Methods 7naloxegol 6Nutrition Assessment 6Counseling 6alvimopan 5Resistance Training 5Psychiatric Rehabilitation 5Exenatide 5Early Intervention, Educational 5Diet Therapy 5Diet 5Sugars 4Mindfulness-Based Stress Reduction 4Injections 4Fibroblast Growth Factor 7 4Educational Status 4Drug Therapy 4Vitamin D 3Therapeutics 3Standard of Care 3Liraglutide 3Interviews as Topic 3Fentanyl 3Cryotherapy 3Cognitive Behavioral Therapy 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Doxorubicin × Other × Clear all
NCT01537029 2018-08-22

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Texas Tech University Health Sciences Center

Phase 4 Completed
15 enrolled 6 charts
BreastOther

Body Weight, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡